Aarthi Jayanthan
Director de Operaciones en Phoenix Molecular Designs Ltd. .
Cargos activos de Aarthi Jayanthan
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Phoenix Molecular Designs Ltd.
 Phoenix Molecular Designs Ltd. Miscellaneous Commercial ServicesCommercial Services Phoenix Molecular Designs operates as a biopharmaceutical company. It focuses on developing first-in-class inhibitors against ribosomal S6 kinase (RSK), an important drug target for cancer, heart disease, and inflammation. The company was founded by Sandra Dunn in 2012 and is headquartered in Vancouver, Canada. | Director de Operaciones | - | - |
| Director Técnico/Científico/I+D | - | - |
Historial de carrera de Aarthi Jayanthan
Estadísticas
Internacional
| Canadá | 2 |
Operativa
| Chief Operating Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectorial
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Phoenix Molecular Designs Ltd.
Phoenix Molecular Designs Ltd. Miscellaneous Commercial ServicesCommercial Services Phoenix Molecular Designs operates as a biopharmaceutical company. It focuses on developing first-in-class inhibitors against ribosomal S6 kinase (RSK), an important drug target for cancer, heart disease, and inflammation. The company was founded by Sandra Dunn in 2012 and is headquartered in Vancouver, Canada. | Commercial Services |
- Bolsa de valores
- Insiders
- Aarthi Jayanthan
- Experiencia
